Our previous studies showed that RFX1 regulates the immune-related genes CD11a and CD70 by affecting the epigenetic modifications of the two genes’ loci in CD4+ T cells and that downregulation of RFX1 in CD4+ T cells contributes to the autoimmune response of SLE patients16,21. This evidence concerns the gene CD70 and systemic lupus erythematosus.